Cerebrospinal fluid homocysteine, but not plasma homocysteine, is associated with markers of tau pathology and neurodegeneration
Journal of Alzheimer’s Disease · 2026
DOI: 10.1177/13872877261481063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2026. Verfasst von Ji Hyung Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Chungbuk National University Hospital, Cheongju, Republic of Korea. Hauptthemen laut MEDLINE: Homocysteine, tau Proteins, Alzheimer Disease, Cognitive Dysfunction. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
Background
Growing evidence links cardiovascular health to Alzheimer's disease (AD). While elevated plasma homocysteine (Hcy) is associated with cognitive decline, the relationship between cerebrospinal fluid (CSF) Hcy and the core pathological biomarkers of AD remains unclear.
Objective
This study aimed to investigate the associations of CSF Hcy and plasma Hcy with CSF amyloid-β (Aβ 42 ), phosphorylated tau (p-tau), and total tau (t-tau).
Methods
A total of 294 non-demented participants (110 cognitively normal, 184 with mild cognitive impairment) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database were analyzed. Multivariate linear regression was used to analyze the relationships between CSF and plasma Hcy levels and CSF Aβ 42 , phosphorylated tau (p-tau), and total tau (t-tau). Logistic regression analyses assessed the association between Hcy levels and Aβ 42 positivity, tau positivity, and neurodegeneration positivity.
Results
CSF Hcy levels showed significant positive associations with CSF p-tau and t-tau, as well as tau and neurodegeneration positivity. In contrast, no significant association was found between CSF Hcy and Aβ 42 pathology. Notably, plasma Hcy was not associated with any AD-related biomarkers.
Conclusions
CSF Hcy, rather than plasma Hcy, was associated with markers of tau pathology and neurodegeneration in non-demented older adults. These findings suggest that CSF Hcy may be more closely associated with tau-related pathological processes during the pre-dementia stages of AD. Further research is needed to explore the mechanisms underlying these associations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Chungbuk National University Hospital, Cheongju, Republic of Korea.
- Department of Psychiatry, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.
- Department of Psychiatry, College of Medicine Chungbuk National University, Cheongju, Republic of Korea.
ORCID-Profile: Ji Hyung Lee, Joon Hyung Jung
Zitieren
APA
Lee, J. H., Won, G. H., Lee, S. I., Shin, C. J., Son, J. W., Kim, S., Ju, G., Chung, S., Jung, J. H., & Alzheimer's Disease Neuroimaging Initiative (2026). Cerebrospinal fluid homocysteine, but not plasma homocysteine, is associated with markers of tau pathology and neurodegeneration. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877261481063
Vancouver
Lee JH, Won GH, Lee SI, Shin CJ, Son JW, Kim S, et al. Cerebrospinal fluid homocysteine, but not plasma homocysteine, is associated with markers of tau pathology and neurodegeneration. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877261481063
BibTeX
@article{Lee2026,
author = {Lee, Ji Hyung and Won, Geun Hui and Lee, Sang-Ick and Shin, Chul-Jin and Son, Jung-Woo and Kim, Siekyeong and Ju, Gawon and Chung, Seungwon and Jung, Joon Hyung and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {Cerebrospinal fluid homocysteine, but not plasma homocysteine, is associated with markers of tau pathology and neurodegeneration},
journal = {Journal of Alzheimer’s Disease},
year = {2026},
doi = {10.1177/13872877261481063}
}
EUVIMED